Thursday, January 05, 2023 9:47:50 AM
Prostaglandin-endoperoxide_synthase_2, also known as cyclooxygenase-2 or COX-2.
When inhibited by Cox-2 inhibitors (NSAIDS) like Celebrex, they can reduce swelling and pain.
https://my.clevelandclinic.org/health/drugs/23119-cox-2-inhibitors#:~:text=COX%2D2%20inhibitors%20are%20a,inhibitor%20available%20in%20the%20U.S.
There is evidence that pain medications other than opioids are as effective if not more. That is good news for the makers of those medications, the NOPAIN act should benefit them.
https://www.nsc.org/getmedia/8ecdc0e5-ae58-43e8-b98b-46c205e1c2b2/evidence-efficacy-pain-medications.pdf
Nonetheless, NSAIDS are not opioids, and the question in play is whether or not BIEL has sufficient evidence that RecoveryRx will reduce the use of opioids. There doesn't appear to be any such clinical evidence.
"Great minds discuss ideas
average minds discuss events
small minds discuss people"
- E. Roosevelt
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
